No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project

Background Despite successful antiretroviral therapy, people living with human immunodeficiency virus (PLWH) experience higher rates of age-related morbidity, including abnormal brain structure, brain function, and cognitive impairment. This has raised concerns that PLWH may experience accelerated aging-related brain pathology. Methods We performed a multicenter longitudinal study of 134 virologically suppressed PLWH (median age, 56.0 years) and 79 demographically similar human immunodeficiency virus (HIV)-negative controls (median age, 57.2 years). To measure cognitive performance and brain pathology, we conducted detailed neuropsychological assessments and multimodality neuroimaging (T1-weighted, T2-weighted, diffusion magnetic resonance imaging [MRI], resting-state functional MRI, spectroscopy, arterial spin labeling) at baseline and at 2 years. Group differences in rates of change were assessed using linear mixed effects models. Results One hundred twenty-three PLWH and 78 HIV-negative controls completed longitudinal assessments (median interval, 1.97 years). There were no differences between PLWH and HIV-negative controls in age, sex, years of education, smoking or alcohol use. At baseline, PLWH had poorer global cognitive performance (P < .01), lower gray matter volume (P = .04), higher white matter hyperintensity load (P = .02), abnormal white matter microstructure (P < .005), and greater brain-predicted age difference (P = .01). Longitudinally, there were no significant differences in rates of change in any neuroimaging measure between PLWH and HIV-negative controls (P > .1). Cognitive performance was longitudinally stable in both groups. Conclusions We found no evidence that middle-aged PLWH, when receiving successful treatment, are at increased risk of accelerated aging-related brain changes or cognitive decline over 2 years.

[1]  J. Kramer,et al.  Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years , 2017, Journal of acquired immune deficiency syndromes.

[2]  Robert Leech,et al.  Gray and White Matter Abnormalities in Treated Human Immunodeficiency Virus Disease and Their Relationship to Cognitive Function , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Joanna M. Wardlaw,et al.  Risk and protective factors for structural brain ageing in the eighth decade of life , 2017, Brain Structure and Function.

[4]  David J. Sharp,et al.  Increased brain-predicted aging in treated HIV disease , 2017, Neurology.

[5]  K. Ruxrungtham,et al.  Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis , 2017, HIV medicine.

[6]  D. Sharp,et al.  Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy , 2017, AIDS.

[7]  Daniel Schonfeld,et al.  The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study , 2017, Human brain mapping.

[8]  Thomas Doring,et al.  Longitudinal assessment of subcortical gray matter volume, cortical thickness, and white matter integrity in HIV‐positive patients , 2016, Journal of magnetic resonance imaging : JMRI.

[9]  Kilian M. Pohl,et al.  Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification , 2016, Human brain mapping.

[10]  D. Sharp,et al.  White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy , 2016, AIDS.

[11]  P. Reiss,et al.  Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy , 2016, AIDS.

[12]  D. Sharp,et al.  White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment , 2016, AIDS.

[13]  P. Reiss,et al.  HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls , 2016, AIDS.

[14]  Tony W Wilson,et al.  Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV‐infected older adults , 2015, Human brain mapping.

[15]  S. Gange,et al.  Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  I. Deary,et al.  Cigarette smoking and thinning of the brain's cortex , 2015, Molecular Psychiatry.

[17]  P. Reiss,et al.  Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  C. Murrill,et al.  Global epidemiology of HIV. , 2014, Infectious disease clinics of North America.

[19]  Torsten Rohlfing,et al.  Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study , 2014, Neurobiology of Aging.

[20]  Stephen M. Smith,et al.  Permutation inference for the general linear model , 2014, NeuroImage.

[21]  J. Skarbinski,et al.  Excess Burden of Depression among HIV-Infected Persons Receiving Medical Care in the United States: Data from the Medical Monitoring Project and the Behavioral Risk Factor Surveillance System , 2014, PloS one.

[22]  Michael J. Taylor,et al.  Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy , 2013, Journal of NeuroVirology.

[23]  Abraham Z Snyder,et al.  Pathways to neurodegeneration , 2013, Neurology.

[24]  A. Winston,et al.  Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy , 2012, Neuroradiology.

[25]  Florin Vaida,et al.  Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures , 2012, Journal of acquired immune deficiency syndromes.

[26]  James T. Becker,et al.  Factors affecting brain structure in men with HIV disease in the post-HAART era , 2012, Neuroradiology.

[27]  A. Roverato,et al.  Premature age-related comorbidities among HIV-infected persons compared with the general population. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  David E. Ross.  Review of longitudinal studies of MRI brain volumetry in patients with traumatic brain injury , 2011, Brain injury.

[29]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[30]  D. Richman,et al.  Resting cerebral blood flow , 2009, Neurology.

[31]  C. Studholme,et al.  Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy , 2009, Journal of NeuroVirology.

[32]  K. Marinković,et al.  Alcohol: Effects on Neurobehavioral Functions and the Brain , 2007, Neuropsychology Review.

[33]  P. Matthews,et al.  Risk factors for progression of brain atrophy in aging , 2005, Neurology.

[34]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[35]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[36]  T. Jernigan,et al.  Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. , 1998, Archives of neurology.

[37]  K. Marder,et al.  Serial MRI in HIV Infection With and Without Neurologic Impairment. , 1997, Journal of neuro-AIDS.

[38]  D. Sharp,et al.  Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers , 2017, The Journal of infectious diseases.

[39]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .